Introducing novel toluidine sulfonamide EL102, a potential chemotherapeutic in prostate cancer

A. Toner; F. J. Giles; F. J. Sullivan; K. Walsh; G. Durkan; E. Rogers; J. D. Lewis

Introducing novel toluidine sulfonamide EL102, a potential chemotherapeutic in prostate cancer

A. Toner
, F. J. Giles
, F. J. Sullivan
, K. Walsh
, G. Durkan
, E. Rogers
, J. D. Lewis

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English
Journal	Bju International
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

TY - JOUR

T1 - Introducing novel toluidine sulfonamide EL102, a potential chemotherapeutic in prostate cancer

AU - Toner, A.

AU - Giles, F. J.

AU - Sullivan, F. J.

AU - Walsh, K.

AU - Durkan, G.

AU - Rogers, E.

AU - Lewis, J. D.

PY - 2013

Y1 - 2013

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318809700124&KeyUID=WOS:000318809700124

M3 - Article

JO - Bju International

JF - Bju International

ER -

Introducing novel toluidine sulfonamide EL102, a potential chemotherapeutic in prostate cancer

UN SDGs

Other files and links

Cite this